Medical Summary & Research Professional entered the industry of Business Services (Unclassified) in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 561499, which describes it as a Business Services (Unclassified). For further clarification, the SIC classifies this business under the code 7389 and described it as a Business Services (Unclassified). The business provides service to the B2B market.
To acquire more information, please contact by calling (320) 485-3700 during business hours. You can also write to the business’ Single Location at 220 West Camellia Avenue, Mcallen, Texas TX 78501. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Medical Summary & Research Professional |
| Place of Business: | 220 West Camellia Avenue, Mcallen, TX 78501 |
| Contact Number: | (320) 485-3700 |
| Type of Service: | Business Services (Unclassified) |
| SIC Number: | 7389 |
| NAICS Number: | 561499 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Income/Year: | $50.000 to $99.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Medical Summary & Research Professional is a company operating from Hidalgo, Texas providing professional Business Services (Unclassified) and relevant B2B variables. It was founded in 0 and registered with the SIC code 7389 as Business Services (Unclassified), and with the NAICS code 561499 as Business Services (Unclassified).
With a current employee count of 1 to 4, Medical Summary & Research Professional has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative at (320) 485-3700 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 220 West Camellia Avenue in Mcallen, Texas 78501 and can be engaged online through the company website at , the company Twitter , and Facebook page .